alopecia areata

Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trial
Clinical Trials Arena
Wed, 02/5/25 - 11:17 am
Alys Pharmaceuticals
FDA
Health Canada
clinical trials
ALY-101
alopecia areata
Incyte blocks US launch of Sun Pharma's alopecia drug
Pharmaphorum
Mon, 11/4/24 - 11:10 am
Incyte
Sun Pharma
Leqselvi
alopecia areata
Pfizer's Litfulo Scores FDA Approval As First Alopecia Treatment For Adolescents
Yahoo/Benzinga
Tue, 06/27/23 - 10:15 am
Pfizer
FDA
Litfulo
alopecia areata
Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival
Fierce Biotech
Wed, 02/15/23 - 10:48 am
Concert Pharmaceuticals
alopecia areata
FDA
breakthrough therapy
deuruxolitinib
Eli Lilly
olumiant
Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity
Stat
Mon, 06/13/22 - 09:49 pm
Eli Lilly
FDA
alopecia areata
olumiant
Chasing Lilly and Pfizer, Concert's JAK inhibitor hits high notes in phase 3 alopecia trial
Fierce Biotech
Mon, 05/23/22 - 10:36 am
Concert Pharmaceuticals
clinical trials
alopecia areata
Eli Lilly
Pfizer
CTP-543
Could This Be the Next Blockbuster Indication for Eli Lilly?
Motley Fool
Thu, 10/21/21 - 10:37 am
Eli Lilly
alopecia areata
olumiant
clinical trials
Lilly, Incyte: Olumiant Superior to Placebo in Scalp Hair Regrowth as Early as 24 Weeks
Marketwatch
Fri, 10/1/21 - 10:51 am
Lilly
Incyte
clinial trials
olumiant
alopecia areata
Lilly has a bad hair day as Pfizer rival hits the mark in alopecia
Pharmaforum
Wed, 08/4/21 - 10:50 pm
Eli Lilly
Incyte
Pfizer
alopecia areata
ritlecitinib
clinical trials
Lilly to seek first approval of an autoimmune drug for hair loss
BioPharma Dive
Wed, 04/21/21 - 11:26 pm
Eli Lilly
alopecia areata
baricitinib
clinical trials
Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment
NASDAQ
Wed, 03/3/21 - 10:53 am
Eli Lilly
Incyte
baricitinib
alopecia areata
Concert gets BTD for alopecia drug, setting up a late-stage showdown with giant rival Pfizer
Endpoints
Wed, 07/8/20 - 10:45 am
Concert Pharmaceuticals
alopecia areata
FDA
CTP-543
breakthrough therapies
Lilly, Incyte get FDA breakthrough therapy status for baricitinib to treat alopecia areata
Pharmaceutical Business Review
Tue, 03/17/20 - 11:59 am
Eli Lilly
Incyte
breakthrough therapy
FDA
baricitinib
alopecia areata
Concert Pharmaceuticals completes enrollment in second open label trial of CTP-543 in alopecia areata
Pharmaceutical Business Review
Wed, 09/18/19 - 10:05 am
Concert Pharmacueticals
clinical trials
CTP-543
alopecia areata
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss
Xconomy
Tue, 09/3/19 - 10:28 am
Concert Pharmaceuticals
Pfizer
JAK inhibitors
CTP-543
alopecia areata
Aclaris hammered as hair loss drug flops in PhII, days after FDA took issue with Eskata ads
Endpoints
Thu, 06/27/19 - 09:37 am
Aclaris
Rigel Pharma
alopecia areata
ATI-502
clinical tirals
Pfizer begins phase 2b/3 trial of PF-06651600 to treat alopecia areata
Pharmaceutical Business Review
Fri, 01/4/19 - 09:12 am
Pfizer
clinical trials
PF-06651600
JAK3 inhibitors
alopecia areata
Pfizer’s JAK inhibitors improve hair regrowth in patients with alopecia areata
Pharmaceutical Business Review
Mon, 09/17/18 - 09:52 am
Pfizer
JAK inhibitors
alopecia areata
clinical trials
PF-06651600
PF-06700841
After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug
Endpoints
Mon, 07/10/17 - 09:24 am
FDA
clinical trials
Concert Pharmaceuticals
CTP-543
alopecia areata
hair loss
FDA forces Concert Pharma to hit the brakes on a mid-stage study so it can review tox studies
Endpoints
Wed, 05/17/17 - 09:34 am
FDA
Concert Pharmaceuticals
clinical trials
CTP-543
alopecia areata